Delivery Order SPE2DE21D7010-SPE2D626F663L
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc. was awarded a delivery order valued at $12,607.94 by the Defense Logistics Agency Medical Supply Chain on June 26, 2025, for the procurement of RELINE open implants. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by July 17, 2025, and will be performed at Nuvasive's San Diego, California location. This award was made through open competition with no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and implants, has been awarded a $39,829.90 delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract, designated as RELINE-ONE, is structured as a fixed-price delivery order with economic price adjustment mechanisms and carries no set-aside designation, indicating open market competition. The place of performance is San Diego,...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and implants, was awarded a $12.43K fixed-price delivery order with economic price adjustment for RELINE MAS IMPLANTS by the Defense Logistics Agency (DLA) Medical Supply Chain on September 9, 2025. The contract, with an ultimate completion date of October 3, 2025, carries no set-aside designation, indicating open market competition. Performance will take place in San Diego, California. This delivery...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $47,148.17 for RELINE MAS IMPLANTS on July 22, 2025. The contract utilizes a fixed-price with economic price adjustment pricing structure and carries no set-aside designation, indicating open market competition. The work will be performed in San Diego, California, with an ultimate completion date of August 15, 2025. This delivery order is funded by the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $15,686.10 delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain on June 17, 2025, for RELINE MAS implants. The contract utilizes a fixed-price structure with economic price adjustment provisions and has an ultimate completion date of June 18, 2025. This award was made without set-aside designation, reflecting Nuvasive's competitive success in open...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $46,066.90 fixed-price delivery order (Contract No. 4568371925, RELINE-ONE) by the Defense Logistics Agency (DLA) Medical Supply Chain on May 28, 2025. The delivery order, which utilizes an economic price adjustment mechanism, is scheduled for ultimate completion on May 29, 2025, and will be performed in San Diego, California. This award was made without a set-aside designation,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F663LDelivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,646.10 fixed-price delivery order (Contract #4570184048) on December 2, 2025, for RELINE OPEN IMPLANTS. This delivery order, issued without set-aside designation, is funded through the Defense Logistics Agency Medical Supply Chain and includes an economic price adjustment mechanism to address cost fluctuations. Performance is scheduled for completion by December 3, 2025, and will be conducted at Nuvasive's San Diego facility. The RELINE OPEN IMPLANTS product is a specialized spinal surgery device designed to support advanced orthopedic and neurosurgical procedures across Department of Defense and Veterans Health Administration medical facilities. This delivery order is issued under Nuvasive's broader procurement relationship with federal healthcare agencies, including an $8 million Blanket Purchase Agreement with the Defense Health Agency (effective through March 2027) structured as an Indefinite Delivery/Indefinite Quantity contract vehicle. Through this strategic framework and related DLA Medical Supply Chain contracts, Nuvasive supplies comprehensive spinal fusion devices, interbody implants, bone graft materials, and specialized surgical instruments that support the operational readiness and medical mission effectiveness of military and veteran healthcare systems. The company competes actively in open market federal procurements and has demonstrated sustained capability in delivering critical orthopedic and neurosurgical technologies required for complex surgical procedures across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 12/1/25 |